Jeffrey A. Berman, MD, FASAM is a Diplomate and Fellow of the American Society of Addiction Medicine. He is the Executive Medical Director of Discovery Institute for Addictive Disorders in Marlboro, NJ and Clinical Assistant Professor of Psychiatry at the Robert Wood Johnson Medical School. He was recruited from Bergen Regional Medical Center, NJ’s largest acute psychiatric hospital, where he served as Director of Chemical Dependency Services to join Discovery Institute in Marlboro. Dr. Berman is a diplomate of the American Board of Psychiatry and Neurology (ABPN) in Adult and Addiction Psychiatry as well as Psychosomatic Medicine. He has been certified by the American Society of Addiction Medicine since 1988 and is Board Certified in Addiction Medicine (ABAM). Dr. Berman’s area of special interest in research and teaching is Pain Management and Co-occurring Opioid Dependence. He is also a strong advocate for Medication Assisted Treatment (MAT) for the chronic persistent mentally ill. Dr. Berman participated in NIDA’s clinical trials of Buprenorphine/Naloxone for treatment of heroin addiction in 2001. Since then he has developed innovative treatment programs for individuals with Co-occurring disorders as well as Substance Use Disorders. Dr. Berman served as Chief of Psychiatry at Fort Leavenworth, KS including the Department of Defense’s US Disciplinary Barracks located at Fort Leavenworth. He recently retired from the US Army Reserve after 22 years of service which included service in Operations Desert Storm and Iraqi Freedom. He is currently the Psychiatric Consultant to the Department of Immigration Health (DIHS), a division of Homeland security. Prior to coming to New Jersey, he served as Medical Director of Gieisinger Health Care’s Marworth chemical dependency center and consultant to pain management centers in New Jersey and Pennsylvania for issues of addiction, pain and co-occurring mood disorders. He has taken an active role in the medical treatment of HIV patients in all of these clinical settings.
SOBA New Jersey4.4 (11 reviews) ADD YOUR REVIEW
Paying for Treatment
- Insurance is Accepted
- Financing is not Available
- Medicare is not Accepted
- Medicaid is not Accepted
SOBA New Jersey offers comprehensive clinical treatment and case management services to individuals suffering from substance abuse and mental health disorders. Our services are specifically designed to treat these disorders and to help our clients build a successful future. SOBA New Jersey sets itself apart from other substance abuse treatment centers by focusing on our clients’ self– sufficiency, their life in recovery outside of treatment, treating the underlying causes of addiction, and by providing a higher quality of care overall. Our Goal: To be the benchmark of excellence for treatment programs. We aim to provide the highest quality of substance abuse and mental health treatment services to those in need. We deliver lasting positive outcomes by offering a 360-degree continuum of care and fully supporting each of our clients in managing their life outside of treatment.
SOBA New Jersey Reviews and Ratings Details
The following is based on a combination of Surveys of Alumni, Staff, Loved Ones, and Reviews and Ratings from around the web.
Reviews at a Glance
- Drug Detox, Alcohol Detox
Our state-of-the-art drug detox center is located in New Brunswick, NJ. Here we provide medically monitored detox and withdrawal management for drugs and alcohol. A stay in our detox typically lasts 5-7 days and helps individuals recover from their habitual drug use in a safe, welcoming, and modern facility. As addictive substances begin to clear from the body withdrawal symptoms begin to manifest, often in severe ways. Our detox program works to manage the withdrawal process. We monitor and treat our clients so they can go through the detoxification process as comfortably and safely as possible.
- Dual Diagnosis Treatment
In co-occurring cases, the mental health disorder tends to be the underlying problem while substance abuse manifests itself as a symptom of that problem. That’s why our team at SOBA New Jersey knows that treatment of both mental health and substance abuse disorders is critical to a client’s successful recovery. A dual diagnosis requires specific treatment outside the realms of traditional addiction treatment centers. The team at SOBA New Jersey is uniquely qualified to treat co-occurring disorders. We are experts in understanding the specific psychological problems and addictive behaviors our clients exhibit and it is with this understanding that we can properly treat both disorders extensively to facilitate a full, comprehensive recovery. Assessing Individuals With A Dual Diagnosis Individuals that enter our treatment program undergo thorough assessments and evaluations. This allows our team to see exactly what their treatment plan will require. It also highlights any co-occurring issues that our treatment plan will need to address. Our team repeats these assessments at specific checkpoints throughout treatment to continually monitor for underlying mental health disorders. Our evaluation process makes sure every client receives the care required.
Jeffrey A. Berman, MD, FASAM - Medical Director and Attending Physician
About the AAC Helpline
American Addiction Centers (AAC) is the leading provider for addiction treatment nationwide, specializing in evidence-based treatment and mental healthcare. With 9 locations across the U.S., AAC has a facility near you that is ready to help you start your journey to sobriety today.
When you call the helpline displayed on Recovery.org, you will be connected with a caring admissions navigator to discuss your options for treatment. Our representatives work solely for AAC and will discuss whether an AAC facility may be an option for you.
Our helpline is offered at no cost to you and with no obligation to enter into treatment. Neither Recovery.org nor AAC receives any commission or other fee that is dependent upon which treatment provider a visitor may ultimately choose.
For more information, visit americanaddictioncenters.org.